| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 August 2024 |
| for |
| SAS BIOPHARM LIMITED |
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 August 2024 |
| for |
| SAS BIOPHARM LIMITED |
| SAS BIOPHARM LIMITED (Registered number: 08640908) |
| Contents of the Financial Statements |
| for the Year Ended 31 August 2024 |
| Page |
| Balance Sheet | 1 |
| SAS BIOPHARM LIMITED (Registered number: 08640908) |
| Balance Sheet |
| 31 August 2024 |
| 31.8.24 | 31.8.23 |
| £ | £ |
| CURRENT ASSETS |
| CREDITORS |
| Amounts falling due within one year | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| ACCRUALS AND DEFERRED INCOME | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| NOTES TO THE FINANCIAL STATEMENTS |
| 1. | STATUTORY INFORMATION |
| SAS BIOPHARM LIMITED is a |
| Registered number: |
| Registered office: |
| The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime. |
| 2. | AVERAGE NUMBER OF EMPLOYEES |
| The average number of employees during the year was NIL (2023 - NIL). |
| 3. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES |
| The following advances and credits to a director subsisted during the years ended 31 August 2024 and 31 August 2023: |
| 31.8.24 | 31.8.23 |
| £ | £ |
| Balance outstanding at start of year |
| Amounts advanced |
| Amounts repaid | ( |
) |
| Amounts written off | - | - |
| Amounts waived | - | - |
| Balance outstanding at end of year |
| Interest, at the rate of 2.25% per annum, has been charged on shareholders' overdrawn loan account. This loan is unsecured and repayable on demand. |
| SAS BIOPHARM LIMITED (Registered number: 08640908) |
| Balance Sheet - continued |
| 31 August 2024 |
| The director acknowledges his responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the director and authorised for issue on |